ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
$3.99 0.08 (2.046%)
Analysed ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) News Sources
JonesResearch Initiates Coverage of AbCellera Biologics Inc. (ABCL)
20-04-2026
yahoo.com
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call
20-04-2026
yahoo.com
Is Jones Trading’s New Coverage of AbCellera (ABCL) Reframing Its Clinical-Stage Platform Narrative?
14-04-2026
yahoo.com
AbCellera Biologics (ABCL) Committed to Leverage Differentiated Technology for Drug Discovery
14-04-2026
yahoo.com
AbCellera (ABCL): Among the Stocks That Could 10x Over the Next 5 Years
02-04-2026
yahoo.com
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
01-04-2026
yahoo.com
3 Penny Stocks With Market Caps Under $19B To Watch
01-04-2026
yahoo.com
AbCellera Biologics Eyes Integrated Biotech Shift; ABCL635 Phase II Data Due in Q3 at Forum
18-03-2026
marketbeat.com
AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says
04-03-2026
marketbeat.com
Why AbCellera (ABCL) Is Up 11.5% After Narrowing Losses And Expanding ESOP Share Capacity – And What's Next
27-02-2026
yahoo.com
What is the current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The current price of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is $3.99.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is $0.08.
ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) since the previous trading day is 2.046%.
What is the most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent average sentiment score for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)?
The most recent sentiment for ABCELLERA BIOLOGICS INC (ABCL:NASDAQ) is .
SEC-8K** Filing Available For ABCELLERA BIOLOGICS INC (ABCL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.